The company have substantially improved the course of an novel therapy for ATTR-CM, leveraging the compound. Early trial information indicates potential improvements for patients affected from this serious disease. The https://attr-cm587777.blogofoto.com/73629029/firm-progresses-cardiac-amyloidosis-therapy-with-the-therapy